Clin Psychopharmacol Neurosci.  2015 Dec;13(3):321-323. 10.9758/cpn.2015.13.3.321.

Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report

• Ram D
• Patil S
• Gowdappa B
• Rajalakshmi I

• KMID: 2171037
• DOI: http://doi.org/10.9758/cpn.2015.13.3.321

Abstract

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.

Keyword

Atomoxetine augment; Treatment resistant panic disorder; Selective norepinephrine reuptake inhibitor

MeSH Terms

Anxiety
Attention Deficit Disorder with Hyperactivity
Citalopram
Clonazepam
Norepinephrine
Panic Disorder*
Panic*
Paroxetine
Propranolol
Risperidone
Sertraline
Atomoxetine Hydrochloride
Citalopram
Clonazepam
Norepinephrine
Paroxetine
Propranolol
Risperidone
Sertraline